Non‐genetic heterogeneity, altered cell fate and differentiation therapy
Abstract Altered capacity for self‐renewal and differentiation is a hallmark of cancer, and many tumors are composed of cells with a developmentally immature phenotype. Among the malignancies where processes that govern cell fate decisions have been studied most extensively is acute myeloid leukemia...
Saved in:
| Main Authors: | Alexander C Lewis, Lev M Kats |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2021-02-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.202012670 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cell–cell heterogeneity in phosphoenolpyruvate carboxylase biases early cell fate priming in Dictyostelium discoideum
by: Kenichi Abe, et al.
Published: (2025-02-01) -
Using single‐cell genomics to understand developmental processes and cell fate decisions
by: Jonathan A Griffiths, et al.
Published: (2018-04-01) -
Mechanotransduction: A Master Regulator of Alveolar Cell Fate Determination
by: Kusum Devi, et al.
Published: (2025-07-01) -
Deciphering the deterministic role of TCR signaling in T cell fate determination
by: Zhen Qin, et al.
Published: (2025-05-01) -
The Jag2/Notch1 signaling axis promotes sebaceous gland differentiation and controls progenitor proliferation
by: Syeda Nayab Fatima Abidi, et al.
Published: (2024-11-01)